LONDON (Reuters) - AstraZeneca's blood-thinning drug Brilinta cut the risk of death or heart attack in patients with a history of previous attacks, according to a major clinical trial that will boost ...
LONDON (Reuters) - AstraZeneca shares jumped 3.5 percent on Thursday, buoyed by U.S. approval for its new heart drug Brilinta as a rival to Plavix, the world's second-biggest selling medicine. But ...
In some cases, factors or conditions could prevent your doctor from prescribing Brilinta due to the risk of harm. These are known as contraindications. The contraindications of Brilinta include: ...
Brilinta (ticagrelor) is a brand-name drug used to reduce the risk of heart-related problems such as heart attack and stroke. Like any medication, it may cause side effects. The mild side effects of ...
Brilinta (ticagrelor) is a prescription drug that’s used to lower the risk of heart attack and stroke. This drug can interact with other medications and some supplements. For example, Brilinta can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results